Biotech

All Articles

F 2G increases $100M for 2nd effort to get new antifungal to market

.After F2G's very first attempt to obtain a new lesson of antifungal to market was thwarted by the F...

Moderna targets $1.1 B in R&ampD spending cuts, drops 5 courses amidst productivity pressures

.Moderna has sworn to reduce R&ampD spending by $1.1 billion through 2027. The choice to shrink the ...

Sanofi's $80M bet on Key dystrophy medicine ends in period 3 lose big

.Only 4 months after Sanofi wager $80 thousand in ahead of time cash money on Key Rehabs' losmapimod...

Oncternal stock drains 60% among layoffs, test terminations

.Cancer cells company Oncternal Rehabs is folding all its own medical tests as well as giving up sta...

Roche is actually keeping out chances that its own injectable obesity prospect can at some point illustrate 25% weight loss in late-stage trial

.Roche is actually keeping out hopes that its own injectable weight problems prospect could at some ...

Novo Nordisk hails 'amazing' weight loss lead for dual-acting oral medicine in early test

.Novo Nordisk has actually lifted the top on a stage 1 test of its oral amylin and also GLP-1 recept...

AbbVie files suit BeiGene over blood cancer cells medicine secret method

.Just a few brief full weeks after winning an FDA Fast Track tag for its own investigational BTK deg...

Lilly delivers one-two blow with second tranche of beneficial information on regular blood insulin prospect

.Soon after a beneficial information drop for Eli Lilly's efsitora alfa, the Indianapolis-based firm...

BridgeBio cuts genetics therapy budget plan as professional records let down

.BridgeBio Pharma is actually slashing its own genetics treatment spending plan and also drawing bac...

GSK surrenders HSV vaccine wishes after phase 2 neglect, yielding ethnicity to Moderna, BioNTech

.GSK's attempt to develop the very first vaccine for genital herpes simplex infection (HSV) has actu...